Skip to main content

Abstract

The assessment and treatment of behavioral and psychiatric disorders in children and adults with Intellectual and developmental disorders is a comprehensive, multi-disciplinary process. A major part of the process involves collecting past medical, family and developmental history; integrating behavioral data with psychiatric ratings scales, direct observation and mental status examination, and formulating differential diagnosis. The next steps involve making a diagnosis that matches available treatments. The treatment process requires careful monitoring and tracking of many parameters. Treatment nonresponse can relate to both pharmacokinetic, pharmacodynamic factors that are in part related to genetic factors. There are many biological and psychosocial factors that will help predict treatment response. It is important to recognize that in many clinical situations, that both children and adults with IDD are quite vulnerable to psychosocial discord and ecological disruptions. The chapter is an effort to synthesize a model that addresses the many issues needed for effective treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 389.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 499.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Fletcher R, Loschen E, Stavrakaki C, First M. Diagnostic manual-intellectual disability (DM-ID): a textbook of diagnosis of mental disorders in persons with intellectual disability. Washington, DC: National Association for the Dually Diagnosed Press and American Psychiatric Association; 2007.

    Google Scholar 

  2. Napolitano DA, Jack SL, Sheldon JB, Williams DC, McAdam DB, Schroeder SR. Drug-behavior interactions in persons with mental retardation and developmental disabilities. Ment Retard Dev Disabil Res Rev. 1999;5(4):322–34.

    Article  Google Scholar 

  3. Poling A, Ehrhardt K. Applied behavioral analysis, social validation and the psychopharmacology of mental retardation. Ment Retard Dev Disabil Res Rev. 1999;5(4):342–7.

    Article  Google Scholar 

  4. Sigafoos J. Communication development and aberrant behaviour in children with developmental disabilities. Educ Train Ment Retard Dev Disabil. 2000;35:168–76.

    Google Scholar 

  5. Carr EG, Levin L, McConnachie G, Carlson JI, Kemp DC, Smith CE. Communication-based intervention for problem behavior: a user’s guide for producing positive change. Baltimore: Paul Brookes; 1994.

    Google Scholar 

  6. Durand VM. Problem behaviour as communication. Behav Change. 1993;10:126–97.

    Article  Google Scholar 

  7. Barnhill J, Pfadt A. Data-based approaches to diagnosing and treating psychiatric disorders in people with developmental disabilities. Introduction to a special issue. Ment Health Aspects Dev Disabil. 2006;9(2).

    Google Scholar 

  8. Totsika V, Toogood S, Hastings RP, Lewis S. Persistence of challenging behaviours in adults with intellectual disability over a period of 11 years. J Intellect Disabil Res. 2008;52:446–57.

    Article  CAS  PubMed  Google Scholar 

  9. Ressler KJ, Nemeroff CB. Depression. In: De Vivo DC, Wang D, Pascual JM, editors. The molecular and genetic basis of neurological and psychiatric disorders. Baltimore: Lippincott Williams Wilkins; 2008. p. 759–75.

    Google Scholar 

  10. Oesterheld JR, Flockhart DA. Pharmacokinetics: cytochrome P450 mediated drug interactions. In: Martin A, Scahill L, Charney DS, et al., editors. Pediatric psychopharmacology: principles and practice. New York: Oxford University Press; 2003. p. 54–66.

    Google Scholar 

  11. Anderson GM, Veenstra-VanderWeele J, Cook EH. Pharmacogenetics in child and adolescent psychopharmacology. In: Scahill L, Charney D, Leckman JF, editors. Child and adolescent psychopharmacology. New York: Oxford University Press; 2002. p. 84–98.

    Google Scholar 

  12. Barnhill J. Data management systems in the treatment of people with intellectual disabilities: a model for psychopharmacologists. Ment Health Aspects Dev Disabil. 2006;9(2):41–3.

    Google Scholar 

  13. Kerner B, Reus VI, Freimer NB. Bipolar disorder. In: De Vivo DC, Wang D, Pascual JM, editors. The molecular and genetic basis of neurological and psychiatric disorders. Baltimore: Lippincott Williams Wilkins; 2008. p. 776–87.

    Google Scholar 

  14. Bartels M, Hudziak JJ. Genetically informative designs in the study of resilience in developmental psychopathology. Child Adolesc Psychiatr Clin North Am. 2007;16(2):323–40.

    Article  Google Scholar 

  15. Lee C, Barnhill J. Where do positive supports fit into the treatment of children with ASD: psychopharmacology and family systems. NADD Bull. 2012;15(2):28–34.

    CAS  Google Scholar 

  16. Volk D, Lewis DA. Schizophrenia. In: De Vivo DC, Wang D, Pascual JM, editors. The molecular and genetic basis of neurological and psychiatric disorders. Baltimore: Lippincott Williams Wilkins; 2008. p. 788–801.

    Google Scholar 

  17. Deb S, Kwok H, Bertelli M, Salvador-Carulla L, Bradley E, Torr J, Barnhill J. International guide to prescribing psychotropic medication for the management of problem behaviors in adults with intellectual disabilities. World Psychiatry. 2009;8:181–6.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Ghaemi N. The rise and fall of the biopsychosocial model: reconciling art and science in psychiatry. Baltimore: Johns Hopkins Press; 2010.

    Google Scholar 

  19. Snyderman R. Personalized health care in 2013: a status report on the impact of genomics. NC Med J. 2013;74(6):478–84.

    Google Scholar 

  20. Dressler LG. Integrating personalized genomic medicine into routine clinical care. NC Med J. 2013;74(6):509–14.

    Google Scholar 

  21. Wang L, McLeod HL, Weinshilboum RM. Genomics and drug response. N Engl J Med. 2011;364(12):1144–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Jonas DE, Wines R. Pharmaco-genomic testing and the prospect of individualized treatment. NC Med J. 2013;74(6):485–90.

    Google Scholar 

  23. Ogren MP, Lombroso PJ. Reversing the effects of fragile X syndrome. J Am Acad Child Adolesc Psychiatry. 2008;47(8):863–7.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Soloman M, Hessl D, Chiu S, Olsen E, Hendren RL. Towards a neurodevelopmental model of clinical case formulation. Psychiatr Clin North Am. 2009;32(1):199–212.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jarrett Barnhill M.D., DFAPA, FAACAP .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Barnhill, J. (2016). Integrated Psychopharmacological Management. In: Rubin, I.L., Merrick, J., Greydanus, D.E., Patel, D.R. (eds) Health Care for People with Intellectual and Developmental Disabilities across the Lifespan. Springer, Cham. https://doi.org/10.1007/978-3-319-18096-0_127

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-18096-0_127

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-18095-3

  • Online ISBN: 978-3-319-18096-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics